Power Market Access in Pharma
From evidence to commercial success, navigate the complexities of value and market access strategy with confidence and precision.
Navigate the shifting market access landscape
Securing market access is more complex than ever. A convergence of scientific, regulatory, economic, and policy pressures – all happening simultaneously across global healthcare systems – is reshaping the access landscape.
Payers are demanding stronger evidence of clinical outcomes and real-world effectiveness. Health systems are shifting toward value-based care. International policy developments – like Most Favored Nation pricing models – are redefining global pricing dynamics. At the same time, technology is transforming how data drives decisions, from real-world evidence to AI-enabled analytics. For life sciences companies, the ability to navigate this evolving environment is critical – not just to launch success, but to long-term impact.
At Deloitte, we help you anticipate, adapt, and stay ahead. With a deep understanding of what matters to payers, providers, and patients, we work across the product lifecycle to shape strategies that unlock access – efficiently, sustainably, and globally.
Access is not a checkpoint – it’s a mindset. And it starts well before launch.
Why partner with us?
We combine strategy, stakeholder insights and AI for measurable market access success. Our global network offers local insights across diverse markets, ensuring tailored strategies. We connect access with medical and commercial strategies, supported by AI-enabled solutions for enhanced decision-making. From early asset evaluation to post-launch optimisation, we provide comprehensive support. Partner with Deloitte Advisory for effective market access solutions.
Our Thinking
We believe that future-ready value & access strategies are:
- Proactive – planned early and refined often
- Evidence-driven – grounded in real-world impact
- Locally informed – tailored to payer realities across geographies
- Integrated – aligned with clinical, commercial, and corporate goals
- AI-enabled – powered by AI, data platforms, digital insights to act smarter
Success lies not in checking regulatory boxes, but in building credible, compelling value stories that resonate across the healthcare ecosystem while considering International policy developments (e.g., MFN). Explore our thinking and uncover the latest perspectives on aligning value, evidence, and patient access.
Alexander Mirow
Leon Struett
Amaury Negret
